Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Masatomo Ishikawa"'
Autor:
Kiyomitsu Ota, Tomihisa Niitsu, Kengo Oishi, Keita Idemoto, Maria Kato, Jing Liu, Masumi Tachibana, Yusuke Nakata, Masayuki Takase, Yasunori Oda, Masatomo Ishikawa, Tasuku Hashimoto, Nobuhisa Kanahara, Yoshimi Iwayama, Tomoko Toyota, Takeo Yoshikawa, Masaomi Iyo
Publikováno v:
Psychiatry Research Communications, Vol 3, Iss 2, Pp 100124- (2023)
This study explored the pathophysiology of bipolar disorder (BD) and schizophrenia (SZ) by examining the associations between the two disorders and single nucleotide polymorphisms (SNPs) involved in the dopamine signaling system. This was a case-cont
Externí odkaz:
https://doaj.org/article/4221ecc01d9d4a4cad90535466b6110a
Autor:
Yusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, Tomihisa Niitsu, Hideki Komatsu, Yasunori Oda, Masatomo Ishikawa, Tadashi Hasegawa, Yu Kamata, Atsushi Yamauchi, Kazuhiko Inazumi, Hiroshi Kimura, Masaomi Iyo
Publikováno v:
Schizophrenia Research: Cognition, Vol 22, Iss , Pp 100186- (2020)
The complex pathophysiology of treatment-resistant schizophrenia (TRS) includes severe positive symptoms but also other symptom domains. The overlapping psychological profiles of schizophrenia and autistic spectrum disorder (ASD) are not established.
Externí odkaz:
https://doaj.org/article/9753bae76c3f4a1aacf52130496649f8
Autor:
Kengo Oishi, Nobuhisa Kanahara, Masayuki Takase, Yasunori Oda, Yusuke Nakata, Tomihisa Niitsu, Masatomo Ishikawa, Yasunori Sato, Masaomi Iyo
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207133 (2018)
BACKGROUND:A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine
Externí odkaz:
https://doaj.org/article/133cbf7ee7e84543a00b6007a1265820
Autor:
Taisuke Yoshida, Masatomo Ishikawa, Tomihisa Niitsu, Michiko Nakazato, Hiroyuki Watanabe, Tetsuya Shiraishi, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tadashi Hasegawa, Masayo Enohara, Atsushi Kimura, Masaomi Iyo, Kenji Hashimoto
Publikováno v:
PLoS ONE, Vol 8, Iss 2 (2013)
Externí odkaz:
https://doaj.org/article/193ef9d2fc7a48368e0ba0342679bee9
Autor:
Taisuke Yoshida, Masatomo Ishikawa, Tomihisa Niitsu, Michiko Nakazato, Hiroyuki Watanabe, Tetsuya Shiraishi, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tadashi Hasegawa, Masayo Enohara, Atsushi Kimura, Masaomi Iyo, Kenji Hashimoto
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42676 (2012)
BACKGROUND: Meta-analyses have identified serum levels of brain-derived neurotrophic factor (BDNF) as a potential biomarker for major depressive disorder (MDD). However, at the time, commercially available human ELISA kits are unable to distinguish b
Externí odkaz:
https://doaj.org/article/6fb5aeafb30444a891930a77fb1d681e
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2010 (2010)
Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated ion channels which are widely distributed in the human brain. Several lines of evidence suggest that two major subtypes (α4β2 and α7) of nAChRs play an important role
Externí odkaz:
https://doaj.org/article/70419cdaab2742fa9837880f3bf8c987
Autor:
Tadashi Hasegawa, Yu Kamata, Masaomi Iyo, Tomihisa Niitsu, Yasunori Oda, Masatomo Ishikawa, Yusuke Nakata, Atsushi Kimura, Nobuhisa Kanahara, Atsushi Yamauchi, Kazuhiko Inazumi, Hiroshi Kimura, Hideki Komatsu
Publikováno v:
Schizophrenia Research: Cognition, Vol 22, Iss, Pp 100186-(2020)
Schizophrenia Research: Cognition
Schizophrenia Research: Cognition
The complex pathophysiology of treatment-resistant schizophrenia (TRS) includes severe positive symptoms but also other symptom domains. The overlapping psychological profiles of schizophrenia and autistic spectrum disorder (ASD) are not established.
Autor:
Nobuhisa Kanahara, Tomihisa Niitsu, Masumi Tachibana, Masatomo Ishikawa, Masaomi Iyo, Motoki Watanabe, Tasuku Hashimoto
Publikováno v:
Asian Journal of Psychiatry. 24:28-32
Objective Dopamine supersensitivity psychosis (DSP) is one of the key factors contributing to the development of antipsychotic treatment-resistant schizophrenia (TRS). We investigated the efficacy of blonanserin, an atypical antipsychotic, for patien
Autor:
Yohei Kawasaki, Takatoshi Sato, Masahiko Nishimoto, Masaomi Iyo, Tatsuki Hata, Masatomo Ishikawa, Tomihisa Niitsu, Yasunori Oda, Mitsugu Endo, Masayuki Inoue, Kohei Ogawa, Yukitsugu Imamura, Atsushi Kimura, Noriaki Hattori, Kiyoshi Fujita, Goro Fukami, Nobuhisa Kanahara, Tadashi Murakami, Akihiro Shiina, Taisuke Yoshida, Masatoshi Suzuki, Yutaka Hosoda, Tasuku Hashimoto, Naoko Takase, Ryota Seki
Publikováno v:
Asian Journal of Psychiatry. 53:102369
Dopamine supersensitivity psychosis (DSP) is a key factor contributing to the development of antipsychotic treatment-resistant schizophrenia. We examined the efficacy and safety of blonanserin (BNS) and olanzapine (OLZ) as adjuncts to prior antipsych
Autor:
Tsuyoshi Sasaki, Kenji Hashimoto, Masumi Tachibana, Tsutomu Kurata, Keiko Okawada, Maki Ishikawa, Hiroshi Kimura, Hideki Komatsu, Masatomo Ishikawa, Tadashi Hasegawa, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tetsuya Shiraishi, Masaomi Iyo
Publikováno v:
Neuropsychiatric Disease and Treatment
Tsuyoshi Sasaki,1,2 Kenji Hashimoto,3 Masumi Tachibana,1 Tsutomu Kurata,1 Keiko Okawada,1 Maki Ishikawa,1 Hiroshi Kimura,2 Hideki Komatsu,2 Masatomo Ishikawa,2 Tadashi Hasegawa,2 Akihiro Shiina,1 Tasuku Hashimoto,2 Nobuhisa Kanahara,3 Tetsuya Shirais